CareFusion Slides After Profit Warning

[Stocks-to-Watch]

Medical technology company CareFusion (CFN) fell 8% this morning after it warned investors that second profits profits will likely fall short of its previous estimates. Its new projection calls for EPS of 41 to 45 cents, below expectations for 46 cents. And the bottom end of its fiscal year guidance range fell by 5 cents.

The company said its antiseptic Chloraprep and some other products have been selling well, just not up to its prior expectations.

“Our Medical Systems segment continues to anchor us, with strong bookings in the quarter and good visibility through the second half of the year,” said Chairman and CEO Kieran Gallahue in a statement. “While we continue to have scenarios that enable us to meet our original, full-year EPS commitments, results in our Procedural Solutions segment through Q2 are softer than we forecasted.”



Original Article Source by Barrons.com